z-logo
open-access-imgOpen Access
Acute Retinal Necrosis - Current Perspectives
Author(s) -
Priyanka MS,
Mihika Dube
Publication year - 2021
Language(s) - English
DOI - 10.47363/jorrr/2021(2)115
Subject(s) - acute retinal necrosis , medicine , etiology , varicella zoster virus , herpes simplex virus , intensive care medicine , disease , clinical trial , uveitis , virus , pediatrics , retinitis , immunology , human cytomegalovirus
Acute retinal necrosis (ARN) is a rare infectious viral uveitis syndrome that may result in visually devastating consequences if not diagnosed and treated timely. The most common etiology involved is varicella zoster virus followed by herpes simplex virus. Over past several decades, initial treatment regimens have shifted from intravenous antivirals requiring hospital admission to oral antivirals with intravitreal antivirals for immediate local control. The true incidence of ARN is not known. Polymerase chain reaction testing from aqueous sample provides a rapid and sensitive method of identifying the viral etiology but one should not delay treatment while awaiting PCR results. Due to its rarity and lack of large-scale prospective research trials, still debate continues over recommended practice guidelines for an ideal treatment protocol. Further studies are needed to refine disease protocols and improve outcomes for this challenging infectious disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here